BEHANDLUNG VON DIABETES

A composition comprising (i) a prepograstrin peptide precursor gene and (ii) an EGF receptor ligand gene capable of being stably introduced into pancreatic cells such that their expression can stimulate pancreatic islet precursor cells for use in a method of treatment of diabetes mellitus.

Saved in:
Bibliographic Details
Main Authors NARDI, RONALD V, BRAND, STEPHEN J
Format Patent
LanguageGerman
Published 15.09.2002
Edition7
Subjects
AGRICULTURE
ANIMAL HUSBANDRY
BEER
BIOCHEMISTRY
CARE OF BIRDS, FISHES, INSECTS
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
DERIVATIVES THEREOF
ENZYMOLOGY
FISHING
FORESTRY
HUMAN NECESSITIES
HUNTING
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
NEW BREEDS OF ANIMALS
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
SUGARS
TRAPPING
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:A composition comprising (i) a prepograstrin peptide precursor gene and (ii) an EGF receptor ligand gene capable of being stably introduced into pancreatic cells such that their expression can stimulate pancreatic islet precursor cells for use in a method of treatment of diabetes mellitus.
Bibliography:Application Number: AT19940926459T